Bajaj Healthcare quarterly results

Q2 FY27 · Jul–Sep 2026

₹ crore	Q2 FY27	Q2 FY26	Change
Revenue	176	148	+18.9%
EBITDA	31.2	27.0	+15.8%
EBITDA margin	17.7%	18.2%	−0.5 pts
Profit before tax	18.5	16.0	+15.7%
Net profit	14.1	11.1	+26.9%
EPS	₹4.19	₹3.53	+18.7%

Every quarter

₹ crore except per share

Tap a line for its trend	Q2 FY27Sep 2026	Q1 FY27Jun 2026	Q4 FY26Mar 2026	Q3 FY26Dec 2025	Q2 FY26Sep 2025	Q1 FY26Jun 2025	Q4 FY25Mar 2025	Q3 FY25Dec 2024	Q2 FY25Sep 2024	Q1 FY25Jun 2024	Q4 FY24Mar 2024	Q3 FY24Dec 2023	Earlier quartersAlpha Plus

Expenses
	176	166	153	161	148	149	154	123	133	132	134	109	Earlier quartersEvery year the company has filed comes with Alpha Plus.
	0.9	0.8	3.0	1.6	1.7	0.9	13.6	2.4	2.6	0.9	6.5	0.8
	177	166	156	163	150	150	168	125	136	133	140	109
	98.4	91.6	92.1	69.4	74.8	69.9	100	72.7	55.0	78.9	50.6	86.6
	−7.0	−5.5	−10.6	11.3	−1.2	10.7	−6.5	−11.8	10.9	−13.3	33.1	−35.4
	19.1	17.5	16.3	15.6	16.5	14.4	15.7	14.7	14.0	12.7	10.6	11.6
	6.0	6.1	5.6	5.9	5.6	5.2	6.1	5.5	7.9	8.4	6.0	6.7
	7.6	7.0	7.6	7.2	7.1	5.6	7.5	6.9	6.8	6.7	7.3	7.4
	34.2	33.3	32.6	34.3	30.9	29.4	33.0	25.6	28.6	29.5	23.5	26.1
	158	150	144	144	134	135	156	114	123	123	131	103
	31.2	28.8	22.7	30.7	27.0	24.5	11.8	21.6	24.5	24.5	16.0	19.5
	23.6	21.7	15.0	23.5	19.9	18.9	4.2	14.8	17.7	17.8	8.7	12.2
Profit
	18.5	16.5	12.4	19.2	16.0	14.5	11.7	11.7	12.4	10.2	9.2	6.3
	0.0	0.0	−33.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	−44.3	0.0
	18.5	16.5	−20.8	19.2	16.0	14.5	11.7	11.7	12.4	10.2	−35.1	6.3
	4.1	2.6	−1.4	3.1	3.5	2.4	0.1	−3.3	4.1	2.2	−3.1	0.8
	4.1	2.6	−1.4	3.1	3.5	2.4	0.1	−3.3	4.1	2.2	−3.1	0.8
	14.1	13.7	−22.9	15.7	11.1	11.8	11.2	11.7	9.5	7.1	−29.9	−2.2
	14.4	13.9	−19.4	16.1	12.4	12.2	11.6	15.0	8.3	8.0	−32.0	5.5
	−0.3	−0.2	−3.4	−0.4	−1.3	−0.3	−0.4	−3.2	1.1	−0.9	2.1	−7.7
	0.2	0.2	0.0	0.2	0.2	0.2	3.5	−0.7	−0.7	−0.7	−3.0	0.1
	14.3	13.9	−22.8	15.9	11.3	12.0	14.6	11.0	8.8	6.4	−32.9	−2.1
Per share
	₹4.19	₹4.07	−₹7.16	₹4.96	₹3.53	₹3.74	₹3.54	₹3.65	₹3.36	₹2.59	−₹10.84	−₹0.80
	₹4.18	₹4.06	−₹7.15	₹4.87	₹3.47	₹3.64	₹3.46	₹3.64	₹3.36	₹2.59	−₹10.84	−₹0.80
Continuing & discontinued operations
	−0.4	−0.3	−2.3	−0.6	−1.8	−0.5	−0.9	−1.2	−0.8	−1.1	−13.4	−7.2
	−0.1	−0.1	1.1	−0.1	−0.5	−0.1	−0.5	2.1	−2.0	−0.2	−15.5	0.5
Other comprehensive income — detail
	0.2	0.2	0.0	0.2	0.2	0.2	3.5	—	—	—	—	—
	0.3	0.3	0.1	0.3	0.3	0.3	4.6	−0.9	—	—	−4.0	0.2
	0.1	0.1	0.0	0.1	0.1	0.1	1.2	—	—	—	—	—
	—	—	—	—	—	—	—	−0.2	0.9	0.9	−1.0	0.0
	—	—	—	—	—	—	—	0.0	−0.2	−0.2	0.0	—
Per share — as-filed variants
	₹4.27	₹4.13	−₹6.08	₹5.10	₹3.95	₹3.85	₹3.67	₹4.66	₹2.96	₹2.91	−₹11.59	₹2.00
	₹4.26	₹4.12	−₹6.07	₹5.01	₹3.88	₹3.75	₹3.59	₹4.65	₹2.96	₹2.91	−₹11.59	₹2.00
	−₹0.08	−₹0.06	−₹1.08	−₹0.14	−₹0.42	−₹0.11	−₹0.13	−₹1.01	₹0.40	−₹0.32	₹0.75	−₹2.80
	−₹0.08	−₹0.06	−₹1.08	−₹0.14	−₹0.41	−₹0.11	−₹0.13	−₹1.01	₹0.40	−₹0.32	₹0.75	−₹2.80
Regulatory disclosures — filed alongside, not part of the P&L
	6.1	—	5.2	—	11.3	—	5.3	—	—	—	—	—
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	84.5	79.5	71.5	80.5	74.3	68.2	60.5	61.9	67.1	66.7	50.2	57.3
	48.1%	48.0%	46.7%	49.9%	50.2%	45.9%	39.2%	50.4%	50.4%	50.4%	37.5%	52.8%
Adjusted (ex-exceptional items) — derived
	18.5	16.5	12.4	19.2	16.0	14.5	11.7	11.7	12.4	10.2	9.2	6.3
	0.0	0.0	−33.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	−44.3	0.0
	14.1	13.7	8.2	15.7	11.1	11.8	11.2	11.7	9.5	7.1	10.4	−2.2
	₹4.19	₹4.07	₹2.56	₹4.96	₹3.53	₹3.74	₹3.54	₹3.65	₹3.36	₹2.59	₹3.78	−₹0.80

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

BAJAJHCARE₹314.45

Bajaj Healthcare Limited

· Pharma & Health

Annual Quarterly₹ CrorePeersTHEMISMED LINCOLN WANBURY SIGACHI AHCL ANUHPHR AMRUTANJANMcap ₹1,059 Cr

View

In ₹ Crore except Per Share 3 Months Ending	Q3 FY24 31/12/2023	Q4 FY24 31/03/2024	Q1 FY25 30/06/2024	Q2 FY25 30/09/2024	Q3 FY25 31/12/2024	Q4 FY25 31/03/2025	Q1 FY26 30/06/2025	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026	Q2 FY27 30/09/2026
Revenue from Operations	108.6	133.9	132.2	133.1	122.8	154.5	148.8	147.9	161.2	153.1	165.6	175.9
Other Income	0.8	6.5	0.9	2.6	2.4	13.6	0.9	1.7	1.6	3.0	0.8	0.9
Total Income	109.4	140.4	133.1	135.7	125.2	168.0	149.7	149.6	162.9	156.0	166.4	176.8
Expenses
+ Cost of Materials Consumed	86.6	50.6	78.9	55.0	72.7	100.5	69.9	74.8	69.4	92.1	91.6	98.4
+ Changes in Inventories	-35.4	33.1	-13.3	10.9	-11.8	-6.5	10.7	-1.2	11.3	-10.6	-5.5	-7.0
+ Employee Benefit Expense	11.6	10.6	12.7	14.0	14.7	15.7	14.4	16.5	15.6	16.3	17.5	19.1
+ Finance Costs	6.7	6.0	8.4	7.9	5.5	6.1	5.2	5.6	5.9	5.6	6.1	6.0
+ Depreciation & Amortisation	7.4	7.3	6.7	6.8	6.9	7.5	5.6	7.1	7.2	7.6	7.0	7.6
+ Other Expenses	26.1	23.5	29.5	28.6	25.6	33.0	29.4	30.9	34.3	32.6	33.3	34.2
Total Expenses	103.0	131.2	122.9	123.2	113.5	156.3	135.2	133.6	143.6	143.6	150.0	158.3
EBITDA	19.5	16.0	24.5	24.5	21.6	11.8	24.5	27.0	30.7	22.7	28.8	31.2
EBIT	12.2	8.7	17.8	17.7	14.8	4.2	18.9	19.9	23.5	15.0	21.7	23.6
Profit
PBT before Exceptional Items	6.3	9.2	10.2	12.4	11.7	11.7	14.5	16.0	19.2	12.4	16.5	18.5
+ Exceptional Items	0.0	-44.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-33.2	0.0	0.0
Pretax Income	6.3	-35.1	10.2	12.4	11.7	11.7	14.5	16.0	19.2	-20.8	16.5	18.5
+ Deferred Tax	0.8	-3.1	2.2	4.1	-3.3	0.1	2.4	3.5	3.1	-1.4	2.6	4.1
Tax Expense	0.8	-3.1	2.2	4.1	-3.3	0.1	2.4	3.5	3.1	-1.4	2.6	4.1
Net Income	-2.2	-29.9	7.1	9.5	11.7	11.2	11.8	11.1	15.7	-22.9	13.7	14.1
+ Net Income — Continuing Ops	5.5	-32.0	8.0	8.3	15.0	11.6	12.2	12.4	16.1	-19.4	13.9	14.4
+ Net Income — Discontinued Ops	-7.7	2.1	-0.9	1.1	-3.2	-0.4	-0.3	-1.3	-0.4	-3.4	-0.2	-0.3
+ Other Comprehensive Income	0.1	-3.0	-0.7	-0.7	-0.7	3.5	0.2	0.2	0.2	0.0	0.2	0.2
Total Comprehensive Income	-2.1	-32.9	6.4	8.8	11.0	14.6	12.0	11.3	15.9	-22.8	13.9	14.3
Per Share
Basic EPS	-0.80	-10.84	2.59	3.36	3.65	3.54	3.74	3.53	4.96	-7.16	4.07	4.19
Diluted EPS	-0.80	-10.84	2.59	3.36	3.64	3.46	3.64	3.47	4.87	-7.15	4.06	4.18
Continuing & Discontinued Operations
+ Discontinued Operations — before Tax	-7.2	-13.4	-1.1	-0.8	-1.2	-0.9	-0.5	-1.8	-0.6	-2.3	-0.3	-0.4
+ Tax — Discontinued Operations	0.5	-15.5	-0.2	-2.0	2.1	-0.5	-0.1	-0.5	-0.1	1.1	-0.1	-0.1
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	—	—	—	3.5	0.2	0.2	0.2	0.0	0.2	0.2
+ Items NOT to be Reclassified to P&L	0.2	-4.0	—	—	-0.9	4.6	0.3	0.3	0.3	0.1	0.3	0.3
+ Tax on Items NOT to be Reclassified	—	—	—	—	—	1.2	0.1	0.1	0.1	0.0	0.1	0.1
+ Tax on Items NOT to be Reclassified — alt tag	0.0	-1.0	0.9	0.9	-0.2	—	—	—	—	—	—	—
+ Tax on Items to be Reclassified — alt tag	—	0.0	-0.2	-0.2	0.0	—	—	—	—	—	—	—
Per Share — as-filed variants
Basic EPS — Continuing Operations	2.00	-11.59	2.91	2.96	4.66	3.67	3.85	3.95	5.10	-6.08	4.13	4.27
Diluted EPS — Continuing Operations	2.00	-11.59	2.91	2.96	4.65	3.59	3.75	3.88	5.01	-6.07	4.12	4.26
Basic EPS — Discontinued Operations	-2.80	0.75	-0.32	0.40	-1.01	-0.13	-0.11	-0.42	-0.14	-1.08	-0.06	-0.08
Diluted EPS — Discontinued Operations	-2.80	0.75	-0.32	0.40	-1.01	-0.13	-0.11	-0.41	-0.14	-1.08	-0.06	-0.08
Regulatory Disclosures — filed alongside, not part of the P&L
Related-party Transactions — During the Period	—	—	—	—	—	5.3	—	11.3	—	5.2	—	6.1
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	57.3	50.2	66.7	67.1	61.9	60.5	68.2	74.3	80.5	71.5	79.5	84.5
Gross Margin %	52.76	37.49	50.41	50.42	50.39	39.17	45.85	50.24	49.95	46.75	48.02	48.05
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	6.3	9.2	10.2	12.4	11.7	11.7	14.5	16.0	19.2	12.4	16.5	18.5
− Exceptional Items (reconciliation)	0.0	-44.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-33.2	0.0	0.0
Net Income Adj (tax-effected)	-2.2	10.4	7.1	9.5	11.7	11.2	11.8	11.1	15.7	8.2	13.7	14.1
EPS Adj	-0.80	3.78	2.59	3.36	3.65	3.54	3.74	3.53	4.96	2.56	4.07	4.19
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	5.00	5.00	5.00	5.00	5.00	5.00	5.00	5.00	5.00	5.00	5.00	5.00
Filed Debt Equity	—	—	—	—	—	0.48	0.48	0.45	0.45	44.00	46.00	48.00
Filed Dscr	—	—	—	—	—	0.44	0.55	0.51	2.43	124.00	247.34	226.00
Filed Iscr	—	—	—	—	—	3.65	3.78	3.87	4.27	323.00	370.21	409.00
Paid Up Equity Capital	13.8	13.8	13.8	15.8	15.8	15.8	15.8	15.8	15.8	16.8	16.8	16.8

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: Q2 FY27 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Bajaj Healthcare Q2 FY27 results (July–September 2026)

Filed with NSE on Saturday, 17 October 2026 at 5:17 pm IST

Bajaj Healthcare (NSE: BAJAJHCARE) reported its Q2 FY27 results (July–September 2026) on Saturday, 17 October 2026 at 5:17 pm IST. Consolidated net profit was ₹14.1 crore, up 26.9% from ₹11.1 crore in Q2 FY26 and up 2.9% from ₹13.7 crore in Q1 FY27. Revenue from operations was ₹176 crore, up 18.9% year on year and up 6.2% from the previous quarter.

Q2 FY26 results (a year earlier): 17 October 2025
Q3 FY27 results due by: 14 February 2027

Q2 FY27 at a glance · consolidated

Net profit: ₹14.1 Cr+26.9% vs Q2 FY26+2.9% vs Q1 FY27
Revenue from operations: ₹176 Cr+18.9% vs Q2 FY26+6.2% vs Q1 FY27
Operating margin (EBIT): 13.4%unchanged vs Q2 FY26+0.3 pts vs Q1 FY27EBIT ₹23.6 Cr
EBITDA: ₹31.2 Cr+15.8% vs Q2 FY26+8.5% vs Q1 FY27margin 17.7%
Earnings per share (basic): ₹4.19+18.7% vs Q2 FY26+2.9% vs Q1 FY27
Net profit margin: 8.0%+0.5 pts vs Q2 FY26−0.3 pts vs Q1 FY27

Questions

What was Bajaj Healthcare's net profit in Q2 FY27?

Consolidated net profit was ₹14.1 crore, up 26.9% from ₹11.1 crore in Q2 FY26 and up 2.9% from ₹13.7 crore in Q1 FY27.

What was Bajaj Healthcare's revenue in Q2 FY27?

Revenue from operations was ₹176 crore, up 18.9% year on year and up 6.2% from the previous quarter.

What is Bajaj Healthcare's net profit margin?

Bajaj Healthcare's net profit margin was 8.0% in Q2 FY27 (net profit as a share of revenue from operations), against 7.5% in Q2 FY26 (up 0.5 percentage points). For FY26 as a whole it was 2.6%.

How were Bajaj Healthcare's Q2 FY27 results?

Both grew from a year earlier: net profit was up 26.9% at ₹14.1 crore and revenue was up 18.9% at ₹176 crore. The operating margin was 13.4%, unchanged from 13.4% a year earlier. Against Q1 FY27, net profit was up 2.9% and revenue up 6.2%.

What was Bajaj Healthcare's operating margin in Q2 FY27?

Operating profit (EBIT — revenue less operating expenses, before finance costs and other income) was ₹23.6 crore, a margin of 13.4%, against 13.1% in Q1 FY27 and 13.4% in Q2 FY26. EBITDA was ₹31.2 crore, 17.7% of revenue.

What was Bajaj Healthcare's net profit in the first half of FY27?

Consolidated net profit for the first half of FY27 (April–September 2026) was ₹27.8 crore, up 21.1% from ₹22.9 crore in the same months a year earlier. Revenue from operations was ₹342 crore, up 15.1%.

What was Bajaj Healthcare's EPS in Q2 FY27?

Basic earnings per share were ₹4.19, against ₹3.53 in Q2 FY26.

What was Bajaj Healthcare's revenue in FY26?

Revenue from operations was ₹611 crore in FY26 (April 2025–March 2026), up 12.6% from ₹543 crore in FY25. It was ₹473 crore in FY24 and ₹673 crore in FY23: down 9.2% over three years, an average fall of 3.2% a year.

When did Bajaj Healthcare announce its Q2 FY27 results?

On Saturday, 17 October 2026 at 5:17 pm IST, in its results filing to the stock exchanges. A year earlier it reported Q2 FY26 on 17 October 2025.

How has Bajaj Healthcare's profit changed over the last four quarters?

Net profit by quarter: a profit of ₹15.7 crore in Q3 FY26, a loss of ₹22.9 crore in Q4 FY26, a profit of ₹13.7 crore in Q1 FY27 and a profit of ₹14.1 crore in Q2 FY27. That is a combined profit of ₹20.6 crore over the four quarters, down 55.0% from ₹45.8 crore in the four quarters before. Revenue from operations: ₹161 crore, ₹153 crore, ₹166 crore and ₹176 crore.

What was Bajaj Healthcare's net profit in FY26?

Consolidated net profit was ₹15.8 crore in FY26 (April 2025–March 2026), down 60.1% from ₹39.5 crore in FY25. It was a loss of ₹83.8 crore in FY24 and a profit of ₹43 crore in FY23: down 63.4% over three years, an average fall of 28.4% a year.

When will Bajaj Healthcare announce its Q3 FY27 results?

Q3 FY27 covers October–December 2026. Listed companies must publish quarterly results within 45 days of the quarter's end (SEBI listing rules, Regulation 33), so the results are due by 14 February 2027. The company tells the exchanges the date of the board meeting at least two working days before it.

Where do these Bajaj Healthcare figures come from?

From Bajaj Healthcare's own consolidated results filings to NSE, in ₹ crore as filed (Q2 FY27 on 17 October 2026). Growth compares the same consolidated figures a year and a quarter earlier.

Consolidated figures from the company's filings to NSE. Every company's results dates this season are in the Q2 FY27 results calendar, part of Alpha Plus.